# Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer

> **NCT07024030** · PHASE2 · COMPLETED · sponsor: **Haitao Niu, MD** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer Patients Undergoing Radical Prostatectomy

## Interventions

- **DRUG:** 0.02mg/kg
- **DRUG:** 0.04mg/kg

## Key facts

- **NCT ID:** NCT07024030
- **Lead sponsor:** Haitao Niu, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07024030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07024030, "Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07024030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*